Add to Favourites
To login click here
The field of companion diagnostic (CDx) development is expanding beyond oncology and into other areas such as hereditary diseases and autoimmune disorders. Machine learning and artificial intelligence are playing a growing role in the development of CDx tests, particularly in the use of digitized pathology slides for identifying biomarkers.
